In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of

Cardinal Health (CAH)Q3 2013 Earnings CallMay 02, 20138:30 am ETExecutivesSally Curley - Senior Vice President of Investor RelationsGeorge S. Barrett - Chairman, Chief Executive Officer and Chairman of Executive CommitteeJeffrey W. Henderson - Chief

NEW YORK (MarketWatch) -- Cardinal Health Inc.reported its third-quarter profit rose 4% to $345 million, or $1.00 a share, from $333 million, or 95 cents a share, a year earlier. Non-GAAP earnings per share were at $1.20, up 28% from 94 cents a year

Here's your Cheat Sheet to earnings...

Cardinal Health (CAH) reports its third quarter earnings on Thursday, May 2, 2013.

Could Walgreen's nonrenewal cripple this drug distributor?

In a report published Wednesday, Citigroup analyst George Hill downgraded the rating on Cardinal Health (NYSE: CAH) from Buy to Neutral, and lowered the price target from $47.00 to $43.00.In the report, Hill noted, “We are downgrading CAH shares to

In a report published Wednesday, Goldman Sachs analyst Robert P. Jones reiterated a Neutral rating on Cardinal Health (NYSE: CAH), but lowered the price target from $50.00 to $48.00.In the report, Jones noted, “On our new estimates, ABC now trades

Realty Income Corporation, Cardinal Health, and Dell are on the list.

Lazard Capital's Thomas Gallucci downgraded shares of Cardinal Health (NYSE: CAH) from Buy to Neutral Tuesday morning.

Bank of America maintained Cardinal Health (NYSE: CAH) with a Buy rating and lowered the price target from $49.00 to $47.00.Bank of America analyst Robert M. Willoughby wrote, "CAH will lose its supply relationship with Walgreens, effective September

NEW YORK, March 19 (Reuters) - Cardinal Health Inc : * down 5.3 percent to $43.50 in premarket afterAmerisourceBergen signs 10-year distribution deal withWalgreen Co

Cardinal Health Inc. (CAH)March 13, 20139:30 am ETExecutivesJeffrey W. Henderson - Chief Financial OfficerAnalystsKipp R.F. Davis - Barclays Capital, Research DivisionPresentationKipp R.F. Davis - Barclays Capital, Research DivisionAll right. So good

Feb 19 - Fitch Ratings has assigned a 'BBB+' rating to Cardinal Health,Inc.'s $1.3 billion proposed senior unsecured notes. Proceeds will be used tofund a portion of the acquisition of AssuraMed,...

Cardinal Health, a distributor of prescription drugs, plans to expand into the growing home health care market with the acquisition of AssuraMed.

Drug wholesaler and medical-products company Cardinal Health will acquire medical supplier AssuraMed for $2.07 billion to reach into a growing home-care market.

Cardinal Health, the second-largest distributor of prescription drugs, is buying AssuraMed, a large medical supplier, in a deal aimed at expanding the business into the growing area of home health care.

Feb 14 - Fitch Ratings has affirmed the ratings of Cardinal Health, Inc. (Cardinal), including the long-term Issuer Default Rating (IDR) at 'BBB+', following the announcement of the company's...

Drug wholesaler Cardinal Health Incsaid it plans to acquire Assuramed, a privately held direct-to-home medical supply distributor, for about $2.

(Reuters) - U.S. drug wholesaler Cardinal Health Incsaid it plans to acquire AssuraMed, a privately held direct-to-home medical supply distributor, for about $2.07 billion.

Feb 14 (Reuters) - U.S. drug wholesaler Cardinal Health Inc said it plans to acquire AssuraMed, a privately helddirect-to-home medical supply distributor, for about $2.07billion.

Feb 14 (Reuters) - Drug wholesaler Cardinal Health Inc said it plans to acquire Assuramed, a privately helddirect-to-home medical supply distributor, for about $2.07billion.

 Cardinal Health (NYSE: CAH) today announcedplans to acquire privately held AssuraMed, a leading provider of medicalsupplies to patients in the home, for $2.07 billion, or $1.94 billion, net ofthe present value of tax benefits.  The acquisition wil

Cardinal Health Incorporated (CAH) maintained its quarterly dividend of 27.5 cents per share.The dividend of $0.275 per common share payable on April 15, 2013, to shareholders of record on April 1, 2013. This is the 114th consecutive regular quarterl

Cardinal Health (CAH) announced that second fiscal quarter 2013 earnings were 93 cents per share, beating estimates of 85 cents per share.The company earned 81 cents per share in the same period last year.Net earnings were $303 million, or 88 cents p

Cardinal Health (CAH)Q2 2013 Earnings CallFebruary 05, 20138:30 am ETExecutivesSally CurleyGeorge S. Barrett - Chairman, Chief Executive Officer and Chairman of Executive CommitteeJeffrey W. Henderson - Chief Financial OfficerAnalystsRicky Goldwasser

Feb 5 (Reuters) - Drug wholesaler Cardinal Health Inc said on Tuesday its quarterly earnings had risen 16 percent,driven by increased sales of generic drugs and medical productssuch as surgical gowns and instruments.

Feb 5 (Reuters) - Drug wholesaler Cardinal Health Inc said on Tuesday that quarterly earnings had risen 16 percent,driven by increased sales of generic medicines and medicalproducts such as surgical gowns and instruments.

Cardinal Health (CAH) reports its second quarter earnings on Tuesday, February 5, 2013.

* To shift Illinois surgical kit manufacturing to Mexico,South Carolina

Jan 30 (Reuters) - Drug wholesaler Cardinal Health Inc said it would sell its procedure kits manufacturingfacility in Illinois and its sterilization processes operationsin Texas as part of a restructuring at its medical business.

In trading on Monday, shares of Cardinal Health, Inc. (NYSE: CAH) crossed above their 200 day moving average of $41.03, changing hands as high as $41.36 per share. Cardinal Health, Inc. shares are currently trading up about 1.1% on the day. The chart

Oct 31 (Reuters) - Moody's says Cardinal Health's dividendincrease is credit negative; ratings unaffected at this time

Cardinal Health (CAH)Q1 2013 Earnings CallOctober 30, 20128:30 am ETExecutivesSally CurleyGeorge S. Barrett - Chairman, Chief Executive Officer and Chairman of Executive CommitteeJeffrey W. Henderson - Chief Financial OfficerAnalystsJohn Kreger - Wil

Cardinal Health posted a 15 percent jump in first-quarter net income as sales of low-cost generic drugs rose.

Oct 30(Reuters) - Drug wholesaler Cardinal Health Inc. on Tuesday reported higher quarterly profits even asrevenue fell as patients converted to generic pharmaceuticalsfrom higher-priced brand name pharmaceuticals.

Oct 31(Reuters) - Drug wholesaler Cardinal Health Inc. on Tuesday reported higher quarterly profits even asrevenue fell as patients converted to generic pharmaceuticalsfrom higher-priced brand name pharmaceuticals.

Cardinal Health (CAH) reports its first quarter earnings on Tuesday, October 30, 2012.

Cardinal Health is below both a large triangle pattern and a trading range.

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Cardinal Health, Inc. (NYSE: CAH) has taken over the #48 spot from Robert Half International Inc. (NYSE: RHI), according to ETF Channel.

The shares of Cardinal Health, Inc. (NYSE:CAH) are still struggling to recover from their earnings-induced drop in early August, after the company offered a weaker-than-expected fiscal-year forecast. What's more, while the stock has gained a bit

Looking at the universe of stocks we cover at Dividend Channel, on 9/27/12, Cardinal Health, Inc. (NYSE: CAH) will trade ex-dividend, for its quarterly dividend of $0.2375, payable on 10/15/12. As a percentage of CAH's recent stock price of $38.

The impact of actual and potential RFP losses raises questions for Cardinal Health.

A long history of returns.

MINYANVILLE ORIGINAL Prepared for Minyanville ChartLabPro buys for August 8 include Ameriprise Financial (AMP) IBM (IBM) and Life Technologies (LIFE). Sells include McDonald's (MCD) Cardinal Health (CAH) and QEP Resources (QEP). Chartlabpro.c

Cardinal Health (CAH)Q4 2012 Earnings CallAugust 02, 20128:00 am ETExecutivesSally CurleyGeorge S. Barrett - Chairman, Chief Executive Officer and Chairman of Executive CommitteeJeffrey W. Henderson - Chief Financial OfficerAnalystsGlen J. Santangelo

Shares of Cigna climb on earnings, while Cardinal Health dips. Thursday’s big winner in the sector is SurModics.

Aug 2 (Reuters) - Cardinal Health Inc said onThursday its fiscal fourth-quarter earnings rose 16.4 percent,driven by strong sales of generic drugs, winning new customersand increased business with existing customers.

Aug 2 (Reuters) - Cardinal Health Inc said onThursday its fiscal fourth-quarter earnings rose, but revenueremained flat as gains in its medical segment were offset by adecline in its pharmaceuticals business.